Heart failure can coexist with obstructive sleep apnea, central sleep apnea or both. These are different breathing problems, so the right treatment cannot be selected from the overall apnea count alone. Assessment should connect the sleep findings with the person's heart condition, symptoms and current treatment.
Establish the breathing pattern
In obstructive events, airflow is limited despite breathing effort. In central events, breathing effort is absent or reduced. A routine PAP download estimates events; it does not replace the measurements needed to diagnose the pattern.
People with significant heart disease may need laboratory sleep testing rather than an uncomplicated home-testing pathway. Bring the current cardiac assessment, medicines and any sleep or oxygen reports so the cardiology and sleep teams can make a coordinated plan.
CPAP and the underlying heart condition
CPAP may be prescribed to treat coexisting obstructive sleep apnea. Its effect should be assessed through comfort, use, breathing control and symptoms. Treating sleep apnea does not replace evidence-based heart-failure treatment or guarantee fewer hospital admissions or longer survival.
Central apnea associated with heart failure requires a separate discussion. Optimising the underlying condition is important, and possible sleep treatments depend on the individual situation. Oxygen or another ventilation mode should not be started from a generic online recipe.
Why ASV needs particular care
Adaptive servo-ventilation (ASV) is a specialised treatment for selected breathing-control problems. A major trial found increased mortality with the ASV approach studied in patients with symptomatic systolic heart failure, left-ventricular ejection fraction at or below 45%, and predominantly central sleep apnea. That history remains relevant to safety.
The 2025 AASM guideline gives conditional ASV recommendations and says treatment in reduced-ejection-fraction heart failure should be limited to experienced centres with close monitoring. This is not permission for unrestricted use: the specialist must also follow the exact device's current contraindications and applicable safety notices. Ordinary bilevel ST should not be assumed to be an interchangeable substitute.
Prepare for the decision
Ask what type of apnea was established, what treatment benefit is expected, how response will be measured and when the plan will be reviewed. If you already use PAP, ask the team to verify your exact mode rather than changing or stopping it yourself on the basis of this article.
New severe breathlessness, chest pain, fainting or marked confusion requires urgent medical assessment. A reassuring PAP score does not rule out a worsening heart condition.
Related reading: Obstructive, central and treatment-emergent sleep apnea